Affimed NV (AFMD)
3.87
+0.14
(+3.61%)
USD |
NASDAQ |
Nov 14, 12:34
Affimed Price: 3.87 for Nov. 14, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 3.80 | 3.90 | 3.63 | 3.735 | 77040.00 |
| Nov 12, 2024 | 3.85 | 3.93 | 3.735 | 3.76 | 71968.00 |
| Nov 11, 2024 | 3.77 | 3.94 | 3.77 | 3.82 | 69860.00 |
| Nov 08, 2024 | 3.90 | 3.940 | 3.715 | 3.85 | 113902.0 |
| Nov 07, 2024 | 3.65 | 3.98 | 3.61 | 3.83 | 231144.0 |
| Nov 06, 2024 | 3.75 | 3.81 | 3.52 | 3.57 | 229176.0 |
| Nov 05, 2024 | 3.24 | 3.720 | 3.24 | 3.66 | 196981.0 |
| Nov 04, 2024 | 3.24 | 3.34 | 3.195 | 3.27 | 34559.00 |
| Nov 01, 2024 | 3.25 | 3.336 | 3.159 | 3.26 | 82975.00 |
| Oct 31, 2024 | 3.31 | 3.315 | 3.17 | 3.23 | 74161.00 |
| Oct 30, 2024 | 3.34 | 3.36 | 3.300 | 3.34 | 53788.00 |
| Oct 29, 2024 | 3.41 | 3.514 | 3.28 | 3.35 | 56723.00 |
| Oct 28, 2024 | 3.38 | 3.480 | 3.31 | 3.37 | 90249.00 |
| Oct 25, 2024 | 3.430 | 3.430 | 3.28 | 3.325 | 87817.00 |
| Oct 24, 2024 | 3.38 | 3.42 | 3.25 | 3.32 | 52375.00 |
| Oct 23, 2024 | 3.48 | 3.48 | 3.33 | 3.39 | 84295.00 |
| Oct 22, 2024 | 3.38 | 3.56 | 3.35 | 3.48 | 66175.00 |
| Oct 21, 2024 | 3.61 | 3.61 | 3.369 | 3.40 | 58990.00 |
| Oct 18, 2024 | 3.30 | 3.58 | 3.28 | 3.55 | 103100.0 |
| Oct 17, 2024 | 3.40 | 3.40 | 3.25 | 3.31 | 74594.00 |
| Oct 16, 2024 | 3.14 | 3.34 | 3.13 | 3.33 | 64054.00 |
| Oct 15, 2024 | 3.09 | 3.16 | 3.07 | 3.125 | 82240.00 |
| Oct 14, 2024 | 3.04 | 3.129 | 2.95 | 3.12 | 324456.0 |
| Oct 11, 2024 | 3.00 | 3.02 | 2.918 | 3.00 | 44600.00 |
| Oct 10, 2024 | 3.09 | 3.105 | 2.93 | 2.99 | 87695.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.99
Minimum
Oct 10 2024
114.00
Maximum
Apr 28 2021
30.08
Average
25.00
Median
Dec 02 2019
Price Benchmarks
| InflaRx NV | 2.14 |
| BioNTech SE | 112.55 |
| Immatics NV | 8.41 |
| CureVac NV | 2.685 |
| ATAI Life Sciences NV | 1.28 |
Price Related Metrics
| PS Ratio | 20.02 |
| Price to Book Value | 1.972 |
| Earnings Yield | -147.4% |
| Market Cap | 60.68M |